{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,7]],"date-time":"2025-11-07T09:54:17Z","timestamp":1762509257276,"version":"build-2065373602"},"reference-count":47,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T00:00:00Z","timestamp":1746057600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T00:00:00Z","timestamp":1746057600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T00:00:00Z","timestamp":1746057600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T00:00:00Z","timestamp":1746057600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T00:00:00Z","timestamp":1746057600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T00:00:00Z","timestamp":1746057600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T00:00:00Z","timestamp":1746057600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Nuclear Medicine and Biology"],"published-print":{"date-parts":[[2025,5]]},"DOI":"10.1016\/j.nucmedbio.2025.108997","type":"journal-article","created":{"date-parts":[[2025,1,22]],"date-time":"2025-01-22T11:36:23Z","timestamp":1737545783000},"page":"108997","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["Quantitative imaging using [18F]F-TZ3108 to assess metabolic-associated fatty liver disease progression and low-carbohydrate diet efficacy"],"prefix":"10.1016","volume":"144-145","author":[{"given":"Zongping","family":"Han","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Min","family":"Yang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lei","family":"Bi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Peizhen","family":"Ye","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yongshan","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pengyuan","family":"He","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Guolong","family":"Huang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hongjun","family":"Jin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jinyu","family":"Xia","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.nucmedbio.2025.108997_bb0005","first-page":"1175","volume":"323","author":"Sheka","year":"2020","journal-title":"Nonalcoholic Steatohepatitis: A Review Jama"},{"key":"10.1016\/j.nucmedbio.2025.108997_bb0010","doi-asserted-by":"crossref","first-page":"1999","DOI":"10.1053\/j.gastro.2019.11.312","article-title":"MAFLD: a consensus-driven proposed nomenclature for metabolic associated fatty liver disease","volume":"158","author":"Eslam","year":"2020","journal-title":"Gastroenterology"},{"key":"10.1016\/j.nucmedbio.2025.108997_bb0015","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1007\/s12072-023-10543-8","article-title":"An international multidisciplinary consensus statement on MAFLD and the risk of CVD","volume":"17","author":"Zhou","year":"2023","journal-title":"Hepatol Int"},{"key":"10.1016\/j.nucmedbio.2025.108997_bb0020","doi-asserted-by":"crossref","first-page":"9132","DOI":"10.3390\/cimb45110573","article-title":"Molecular aspects of MAFLD-new insights on pathogenesis and treatment","volume":"45","author":"Filipovic","year":"2023","journal-title":"Curr Issues Mol Biol"},{"key":"10.1016\/j.nucmedbio.2025.108997_bb0025","doi-asserted-by":"crossref","DOI":"10.3389\/fendo.2023.985858","article-title":"The relationship between metabolic dysfunction-associated fatty liver disease and the incidence rate of extrahepatic cancer","volume":"14","author":"Wei","year":"2023","journal-title":"Front Endocrinol (Lausanne)"},{"issue":"Suppl. 1","key":"10.1016\/j.nucmedbio.2025.108997_bb0030","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1111\/dom.15010","article-title":"Burden of liver complications related to non-alcoholic fatty liver disease in China from 2005 to 2019: observations from the global burden of disease study, 2019","volume":"25","author":"Liu","year":"2023","journal-title":"Diabetes Obes Metab"},{"key":"10.1016\/j.nucmedbio.2025.108997_bb0035","doi-asserted-by":"crossref","DOI":"10.1007\/s12072-024-10660-y","article-title":"MAFLD as part of systemic metabolic dysregulation","author":"Zhao","year":"2024","journal-title":"Hepatol Int"},{"key":"10.1016\/j.nucmedbio.2025.108997_bb0040","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/j.arcmed.2020.11.010","article-title":"Epidemiology, pathogenesis, diagnosis and emerging treatment of nonalcoholic fatty liver disease","volume":"52","author":"Makri","year":"2021","journal-title":"Arch Med Res"},{"key":"10.1016\/j.nucmedbio.2025.108997_bb0045","doi-asserted-by":"crossref","DOI":"10.1177\/20420188241242937","article-title":"Gut microbiota in MAFLD: therapeutic and diagnostic implications","volume":"15","author":"Alghamdi","year":"2024","journal-title":"Ther Adv Endocrinol Metab"},{"key":"10.1016\/j.nucmedbio.2025.108997_bb0050","doi-asserted-by":"crossref","DOI":"10.1177\/20420188221145650","article-title":"Screening for MAFLD: who, when and how?","volume":"14","author":"Pal","year":"2023","journal-title":"Ther Adv Endocrinol Metab"},{"key":"10.1016\/j.nucmedbio.2025.108997_bb0055","doi-asserted-by":"crossref","DOI":"10.3389\/fncel.2021.685201","article-title":"Sigma-1 receptor: a potential therapeutic target for traumatic brain injury","volume":"15","author":"Shi","year":"2021","journal-title":"Front Cell Neurosci"},{"key":"10.1016\/j.nucmedbio.2025.108997_bb0060","doi-asserted-by":"crossref","first-page":"5649","DOI":"10.1007\/s12035-021-02524-5","article-title":"Emerging benefits: pathophysiological functions and target drugs of the Sigma-1 receptor in neurodegenerative diseases","volume":"58","author":"Wu","year":"2021","journal-title":"Mol Neurobiol"},{"key":"10.1016\/j.nucmedbio.2025.108997_bb0065","doi-asserted-by":"crossref","first-page":"909","DOI":"10.1007\/s11307-022-01740-2","article-title":"Evaluation of [(18)F]F-TZ3108 for PET imaging of metabolic-associated fatty liver disease","volume":"24","author":"Huang","year":"2022","journal-title":"Mol Imaging Biol"},{"key":"10.1016\/j.nucmedbio.2025.108997_bb0070","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0076941","article-title":"Sigma-1 receptor chaperone at the ER-mitochondrion interface mediates the mitochondrion-ER-nucleus signaling for cellular survival","volume":"8","author":"Mori","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.nucmedbio.2025.108997_bb0075","first-page":"845","article-title":"The role of Sigma-1 receptor agonist in hepatic ischemiareperfusion injury","volume":"34","author":"Li","year":"2020","journal-title":"J Biol Regul Homeost Agents"},{"key":"10.1016\/j.nucmedbio.2025.108997_bb0080","doi-asserted-by":"crossref","first-page":"733","DOI":"10.3389\/fnins.2019.00733","article-title":"The Sigma-1 receptor in cellular stress signaling","volume":"13","author":"Hayashi","year":"2019","journal-title":"Front Neurosci"},{"key":"10.1016\/j.nucmedbio.2025.108997_bb0085","doi-asserted-by":"crossref","first-page":"596","DOI":"10.1016\/j.cell.2007.08.036","article-title":"Sigma-1 receptor chaperones at the ER-mitochondrion interface regulate ca(2+) signaling and cell survival","volume":"131","author":"Hayashi","year":"2007","journal-title":"Cell"},{"key":"10.1016\/j.nucmedbio.2025.108997_bb0090","first-page":"8","article-title":"Sigma-1 receptor activation induces autophagy and increases Proteostasis capacity in vitro and in vivo","author":"Christ","year":"2019","journal-title":"Cells"},{"key":"10.1016\/j.nucmedbio.2025.108997_bb0095","doi-asserted-by":"crossref","first-page":"3009","DOI":"10.3748\/wjg.v25.i24.3009","article-title":"Biomarkers and subtypes of deranged lipid metabolism in non-alcoholic fatty liver disease","volume":"25","author":"Mato","year":"2019","journal-title":"World J Gastroenterol"},{"key":"10.1016\/j.nucmedbio.2025.108997_bb0100","doi-asserted-by":"crossref","first-page":"1194","DOI":"10.1111\/apt.17722","article-title":"MAFLD fibrosis score: using routine measures to identify advanced fibrosis in metabolic-associated fatty liver disease","volume":"58","author":"Cheung","year":"2023","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.nucmedbio.2025.108997_bb0105","doi-asserted-by":"crossref","first-page":"928","DOI":"10.1007\/s11307-022-01743-z","article-title":"Early diagnosis of murine Sepsis-associated encephalopathy using dynamic PET\/CT imaging and multiparametric MRI","volume":"24","author":"Zhu","year":"2022","journal-title":"Mol Imaging Biol"},{"key":"10.1016\/j.nucmedbio.2025.108997_bb0110","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1186\/s41747-023-00387-0","article-title":"CT-based methods for assessment of metabolic dysfunction associated with fatty liver disease","volume":"7","author":"Hu","year":"2023","journal-title":"Eur Radiol Exp"},{"key":"10.1016\/j.nucmedbio.2025.108997_bb0115","doi-asserted-by":"crossref","first-page":"670","DOI":"10.1038\/s41575-022-00620-y","article-title":"Circulating biomarkers in the diagnosis and management of hepatocellular carcinoma","volume":"19","author":"Johnson","year":"2022","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"10.1016\/j.nucmedbio.2025.108997_bb0120","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1007\/s00261-020-02787-x","article-title":"Hepatic perfusional changes on CT and MRI: a radiology primer","volume":"46","author":"Gunter","year":"2021","journal-title":"Abdom Radiol (NY)"},{"key":"10.1016\/j.nucmedbio.2025.108997_bb0125","doi-asserted-by":"crossref","first-page":"17367","DOI":"10.1038\/s41598-020-74443-9","article-title":"Blood pool activity on F-18 FDG PET\/CT as a possible imaging biomarker of metabolic syndrome","volume":"10","author":"Bang","year":"2020","journal-title":"Sci Rep"},{"key":"10.1016\/j.nucmedbio.2025.108997_bb0130","first-page":"9","article-title":"Total-body imaging: transforming the role of positron emission tomography","author":"Cherry","year":"2017","journal-title":"Sci Transl Med"},{"key":"10.1016\/j.nucmedbio.2025.108997_bb0135","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1016\/B978-0-444-53485-9.00011-8","article-title":"Positron emission tomography","volume":"135","author":"Lameka","year":"2016","journal-title":"Handb Clin Neurol"},{"key":"10.1016\/j.nucmedbio.2025.108997_bb0140","doi-asserted-by":"crossref","first-page":"3624","DOI":"10.7150\/ijms.64458","article-title":"Radiomics based on fluoro-deoxyglucose positron emission tomography predicts liver fibrosis in biopsy-proven MAFLD: a pilot study","volume":"18","author":"Chen","year":"2021","journal-title":"Int J Med Sci"},{"key":"10.1016\/j.nucmedbio.2025.108997_bb0145","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1186\/s13550-018-0420-6","article-title":"Sensitive and early detection of mitochondrial dysfunction in the liver of NASH model mice by PET imaging with (18)F-BCPP-BF","volume":"8","author":"Sakai","year":"2018","journal-title":"EJNMMI Res"},{"key":"10.1016\/j.nucmedbio.2025.108997_bb0150","first-page":"32","article-title":"Synthesis, radiolabelling, and evaluation of [(11)C]PB212 as a radioligand for imaging sigma-1 receptors using PET","volume":"8","author":"Spinelli","year":"2018","journal-title":"Am J Nucl Med Mol Imaging"},{"key":"10.1016\/j.nucmedbio.2025.108997_bb0155","doi-asserted-by":"crossref","first-page":"909","DOI":"10.1007\/s11307-022-01740-2","article-title":"Evaluation of [(18)F]F-TZ3108 for PET imaging of metabolic-associated fatty liver disease","volume":"24","author":"Huang","year":"2022","journal-title":"Mol Imaging Biol"},{"key":"10.1016\/j.nucmedbio.2025.108997_bb0160","doi-asserted-by":"crossref","first-page":"3624","DOI":"10.7150\/ijms.64458","article-title":"Radiomics based on fluoro-deoxyglucose positron emission tomography predicts liver fibrosis in biopsy-proven MAFLD: a pilot study","volume":"18","author":"Chen","year":"2021","journal-title":"Int J Med Sci"},{"key":"10.1016\/j.nucmedbio.2025.108997_bb0165","doi-asserted-by":"crossref","first-page":"1839","DOI":"10.1016\/j.clnu.2023.08.001","article-title":"Novel approach using [(18)F]FTHA-PET and de novo synthesized VLDL for assessment of FFA metabolism in a rat model of diet induced NAFLD","volume":"42","author":"Ustsinau","year":"2023","journal-title":"Clin Nutr"},{"key":"10.1016\/j.nucmedbio.2025.108997_bb0170","doi-asserted-by":"crossref","first-page":"1669","DOI":"10.1039\/C4MD00240G","article-title":"Radiosynthesis and in vivo evaluation of a novel \u03c3(1) selective PET ligand","volume":"5","author":"Jin","year":"2014","journal-title":"Medchemcomm"},{"key":"10.1016\/j.nucmedbio.2025.108997_bb0175","doi-asserted-by":"crossref","first-page":"24","DOI":"10.2174\/1874312901206010024","article-title":"Histological examination of collagen and proteoglycan changes in osteoarthritic menisci","volume":"6","author":"Sun","year":"2012","journal-title":"Open Rheumatol J"},{"key":"10.1016\/j.nucmedbio.2025.108997_bb0180","doi-asserted-by":"crossref","first-page":"16041","DOI":"10.1038\/s41598-017-16077-y","article-title":"Liver-specific deletion of ROR\u03b1 aggravates diet-induced nonalcoholic steatohepatitis by inducing mitochondrial dysfunction","volume":"7","author":"Kim","year":"2017","journal-title":"Sci Rep"},{"key":"10.1016\/j.nucmedbio.2025.108997_bb0185","doi-asserted-by":"crossref","first-page":"927","DOI":"10.1016\/j.jhep.2018.06.008","article-title":"Endoplasmic reticulum stress signalling and the pathogenesis of non-alcoholic fatty liver disease","volume":"69","author":"Lebeaupin","year":"2018","journal-title":"J Hepatol"},{"key":"10.1016\/j.nucmedbio.2025.108997_bb0190","first-page":"12","article-title":"Sigma-1 receptor as a protective factor for diabetes-associated cognitive dysfunction via regulating astrocytic endoplasmic reticulum-mitochondrion contact and endoplasmic reticulum stress","author":"Du","year":"2023","journal-title":"Cells"},{"key":"10.1016\/j.nucmedbio.2025.108997_bb0195","doi-asserted-by":"crossref","first-page":"7349","DOI":"10.1111\/jcmm.14594","article-title":"Sigma-1 receptor protects against ferroptosis in hepatocellular carcinoma cells","volume":"23","author":"Bai","year":"2019","journal-title":"J Cell Mol Med"},{"key":"10.1016\/j.nucmedbio.2025.108997_bb0200","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/j.neuroimage.2016.11.035","article-title":"Estimation of the binding potential BP(ND) without a reference region or blood samples for brain PET studies","volume":"146","author":"Schain","year":"2017","journal-title":"Neuroimage"},{"key":"10.1016\/j.nucmedbio.2025.108997_bb0205","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejphar.2019.172553","article-title":"Endoplasmic reticulum stress: a master regulator of metabolic syndrome","volume":"860","author":"Mohan","year":"2019","journal-title":"Eur J Pharmacol"},{"key":"10.1016\/j.nucmedbio.2025.108997_bb0210","doi-asserted-by":"crossref","first-page":"1154","DOI":"10.1016\/j.dld.2019.03.020","article-title":"The role of sphingosine kinase 2 in alcoholic liver disease","volume":"51","author":"Kwong","year":"2019","journal-title":"Dig Liver Dis"},{"key":"10.1016\/j.nucmedbio.2025.108997_bb0215","doi-asserted-by":"crossref","first-page":"854","DOI":"10.3109\/10715762.2013.830717","article-title":"Mitochondrial dysfunction in non-alcoholic fatty liver disease and insulin resistance: cause or consequence?","volume":"47","author":"Garc\u00eda-Ruiz","year":"2013","journal-title":"Free Radic Res"},{"key":"10.1016\/j.nucmedbio.2025.108997_bb0220","doi-asserted-by":"crossref","first-page":"8713","DOI":"10.3390\/ijms15058713","article-title":"Role of mitochondria in nonalcoholic fatty liver disease","volume":"15","author":"Nassir","year":"2014","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.nucmedbio.2025.108997_bb0225","first-page":"15","article-title":"Low-carbohydrate and low-fat diet with metabolic-dysfunction-associated fatty liver disease","author":"Hu","year":"2023","journal-title":"Nutrients"},{"key":"10.1016\/j.nucmedbio.2025.108997_bb0230","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1016\/j.jhep.2017.05.016","article-title":"Treatment of NAFLD with diet, physical activity and exercise","volume":"67","author":"Romero-G\u00f3mez","year":"2017","journal-title":"J Hepatol"},{"key":"10.1016\/j.nucmedbio.2025.108997_bb0235","doi-asserted-by":"crossref","DOI":"10.1016\/j.envpol.2021.118297","article-title":"High-fat diet exacerbated decabromodiphenyl ether-induced hepatocyte apoptosis via intensifying the transfer of ca(2+) from endoplasmic reticulum to mitochondria","volume":"292","author":"Chen","year":"2022","journal-title":"Environ Pollut"}],"container-title":["Nuclear Medicine and Biology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S096980512500006X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S096980512500006X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,16]],"date-time":"2025-10-16T19:28:44Z","timestamp":1760642924000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S096980512500006X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,5]]},"references-count":47,"alternative-id":["S096980512500006X"],"URL":"https:\/\/doi.org\/10.1016\/j.nucmedbio.2025.108997","relation":{},"ISSN":["0969-8051"],"issn-type":[{"type":"print","value":"0969-8051"}],"subject":[],"published":{"date-parts":[[2025,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Quantitative imaging using [18F]F-TZ3108 to assess metabolic-associated fatty liver disease progression and low-carbohydrate diet efficacy","name":"articletitle","label":"Article Title"},{"value":"Nuclear Medicine and Biology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.nucmedbio.2025.108997","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"108997"}}